DNA Vaccines pp 83-89

Part of the Methods in Molecular Medicine™ book series (MIMM, volume 127)

Needle-Free Injection of DNA Vaccines: A Brief Overview and Methodology

  • Kanakatte Raviprakash
  • Kevin R. Porter

Abstract

The development of needle-free injection originally stemmed from a general apprehension of needle injections, disease transmission by accidental needle-sticks, and the need for effective mass immunization. Naked DNA vaccines, as attractive and universal as they appear, have not produced robust immune responses in test systems. However, proof of principle for DNA vaccines has been validated with a number of vaccine candidates in a variety of test systems, and the concept of DNA vaccines as a generic platform for vaccines still remains viable and attractive. Many avenues are being explored to enhance the immunogenicity of DNA vaccines. The easiest and most straightforward approach that can be quickly transitioned to a clinical trial setting is vaccine delivery by a needle-free jet injector. This approach has shown much potential in a number of cases and should become the lead method for enhancing DNA vaccines. This approach requires no additional development, and with an expanding market and willingness from jet injector manufacturers to produce prefilled syringes, the technique should become feasible for larger phase II/phase III trials.

Key Words

Needle-free biojector DNA vaccine mouse primates 

References

  1. 1.
    Henry, K. and Campbell, S. (1995) Needlestick/sharps injuries and HIV exposure among health care workers. National estimates based on a survey of U.S. hospitals. Minn. Med. 78, 41–44.PubMedGoogle Scholar
  2. 2.
    Hingson, R. A., Davis, H. S., and Rosen, M. (1963) Clinical experience with one and a half million jet injections in parenteral therapy and in preventive medicine. Mil. Med. 128, 525–528.PubMedGoogle Scholar
  3. 3.
    Hingson, R. A., Davis, H. S., and Brailey, R. F. (1957) Mass inoculation of the Salk polio vaccine with the multiple dose jet injector. GP 15, 94–96.PubMedGoogle Scholar
  4. 4.
    Liu, M. A. (2003) DNA vaccines: a review . J. Intern. Med. 253, 402–410.CrossRefPubMedGoogle Scholar
  5. 5.
    Henke, A. (2002) DNA immunization—a new chance in vaccine research? Med. Microbiol. Immunol. (Berl), 191, 187–190.CrossRefGoogle Scholar
  6. 6.
    Corr, M., von Damm, A., Lee, D. J., and Tighe, H. (1999) In vivo priming by DNA injection occurs predominantly by antigen transfer. J. Immunol. 163, 4721–4727.PubMedGoogle Scholar
  7. 7.
    Roy, M. J., Wu, M. S., Barr, L. J., et al. (2000) Induction of antigen-specific CD8+ T cells, T helper cells, and protective levels of antibody in humans by particle-mediated administration of a hepatitis B virus DNA vaccine. Vaccine 19, 764–778CrossRefPubMedGoogle Scholar
  8. 8.
    Schrijver, R. S., Langedijk, J. P., Keil, G. M., et al. (1998) Comparison of DNA application methods to reduce BRSV shedding in cattle. Vaccine 16, 130–134.CrossRefPubMedGoogle Scholar
  9. 9.
    van Rooij, E. M, Haagmans, B. L., de Visser, Y. E., de Bruin, M. G., Boersma, W., and Bianchi, A. T. (1998) Effect of vaccination route and composition of DNA vaccine on the induction of protective immunity against pseudorabies infection in pigs. Vet. Immunol. Immunopathol. 66, 113–126.CrossRefPubMedGoogle Scholar
  10. 10.
    Lundholm, P., Asakura, Y., Hinkula, J., Lucht, E., and Wahren, B. (1999) Induction of mucosal IgA by a novel jet delivery technique for HIV-1 DNA. Vaccine 17, 2036–2042.CrossRefPubMedGoogle Scholar
  11. 11.
    Anwer, K., Earle, K. A., Shi, M., et al. (1999) Synergistic effect of formulated plasmid and needle-free injection for genetic vaccines. . Pharm. Res. 16, 889–895.CrossRefPubMedGoogle Scholar
  12. 12.
    Manam, S., Ledwith, B. J., Barnum, A. B., et al. (2000) Plasmid DNA vaccines: tissue distribution and effects of DNA sequence, adjuvants and delivery method on integration into host DNA. Intervirology 43, 273–281.CrossRefPubMedGoogle Scholar
  13. 13.
    Davis, H. L., Michel, M. L., Mancini, M., Schleef, M., and Whalen, R. G. (1994) Direct gene transfer in skeletal muscle: plasmid DNA-based immunization against the hepatitis B virus surface antigen. Vaccine 12, 1503–1509.CrossRefPubMedGoogle Scholar
  14. 14.
    Aguiar, J. C., Hedstrom, R. C., Rogers, W. O., et al. (2001) Enhancement of the immune response in rabbits to a malaria DNA vaccine by immunization with a needle-free jet device. Vaccine 20, 275–280.CrossRefPubMedGoogle Scholar
  15. 15.
    Rogers, W. O., Baird, J. K., Kumar, A., et al. (2001) Multistage multiantigen heterologous prime boost vaccine for Plasmodium knowlesi malaria provides partial protection in rhesus macaques. Infect. Immun. 69, 5565–5572.CrossRefPubMedGoogle Scholar
  16. 16.
    Raviprakash, K., Ewing, D., Simmons, M., et al. (2003) Needle-free Biojector injection of a dengue virus type 1 DNA vaccine with human immunostimulatory sequences and the GM-CSF gene increases immunogenicity and protection from virus challenge in Aotus monkeys. Virology 315, 345–352.CrossRefPubMedGoogle Scholar

Copyright information

© Humana Press Inc. 2006

Authors and Affiliations

  • Kanakatte Raviprakash
    • 1
  • Kevin R. Porter
    • 1
  1. 1.Viral Diseases DepartmentNaval Medical Research CenterSilver Spring

Personalised recommendations